{
    "2021-12-01": [
        [
            {
                "time": "",
                "original_text": "浙商医美】复锐医疗科技：股权激励计划通过，看好能量源医美王者发展空间",
                "features": {
                    "keywords": [
                        "复锐医疗科技",
                        "股权激励",
                        "医美",
                        "发展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "写意报告丨创新药的国际化与商业化研究",
                "features": {
                    "keywords": [
                        "创新药",
                        "国际化",
                        "商业化"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药：增持计划实施期限届满，累计增持2793.05万股H股",
                "features": {
                    "keywords": [
                        "复星医药",
                        "增持",
                        "H股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【港股通】复星医药(02196)获复星高科技及复星国际累计增持2793.05万股H股",
                "features": {
                    "keywords": [
                        "复星医药",
                        "港股通",
                        "增持",
                        "H股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(02196.HK)控股股东累计增持2793万股H股 增持计划期限届满",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股股东",
                        "增持",
                        "H股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星高科技及其控股股东累计增持复星医药1.09%股份，增持计划期限届满",
                "features": {
                    "keywords": [
                        "复星高科技",
                        "控股股东",
                        "复星医药",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(600196.SH)股东复星高科技及复星国际累计斥资约9.67亿元增持2793.05万股H股",
                "features": {
                    "keywords": [
                        "复星医药",
                        "股东",
                        "增持",
                        "H股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(600196.SH)：增持期满 控股股东方面已累计增持2793.05万股H股",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股股东",
                        "增持",
                        "H股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "融资客青睐6股，宋都股份买入占比高达39.16%",
                "features": {
                    "keywords": [
                        "融资客",
                        "宋都股份",
                        "买入占比"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "房地产"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}